Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS safety_alert · 2017-02-16

Clinical Trial Update: Proton Pump Inhibitor Use is Associated With High Risk of Pneumonia in Chronic Kidney Disease Patients

View source ↗

Summary

A clinical trial update reports that proton pump inhibitor use is associated with a higher risk of pneumonia in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton Pump Inhibitors

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Chronic Kidney Disease, Pneumonia | Status: COMPLETED